KRMD

KORU Medical Systems Inc. (KRMD) | Rumor.io

KORU Medical Systems

KRMD

Attention (50-day avg)0%

Attention rank (50-day avg)#3,323

Bullish sentiment (50-day avg)85%

Price to earnings ratio-50.8

Market capitalization140.6M

Earnings per share-0.04

Dividend yield (TTM)—

Revenue (annual)41.1M

Net income (annual)-2.6M

Social

What share of all stock conversation is about KRMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% 0

Mar 12

KORU Medical Systems reported strong Q4 and full-year 2024 financial results, with net revenues reaching $8.8M (23% YoY growth) and $33.6M (18% YoY growth), respectively.
The company achieved a gross margin of 62.9% in Q4 and 63.4% for the full year, with a cash balance of $9.6M and positive cash flow of $0.8M in Q4.
For 2025, KORU Medical projects net revenues between $38.0-$39.0M (13-16% growth) and gross margins of 61-63%, with expectations to be operational cash flow positive for the full year.

Generated by AI

Sentiment

Of the messages about KRMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% new	95.65% -2.94
Bearish	—	0%	0% -100	4.35% +2.94

Nov 11

KRMD has potential for a significant price increase, possibly reaching $7.00, driven by growing volume and FDA clearance.
The stock's recent run-up and consolidation suggest a strong chart, with the potential for further gains.
KRMD's FDA approval for the FreedomEdge infusion pump is a major catalyst, with the stock already surging in response, and potentially leading to a quadrupling in value.

Generated by AI

Topics

Of the messages about KRMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	—	36.07%
Announcements	—	—	—	21.31%
Analysts	—	—	—	4.92%
Controversies	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	37.7%

Community

Of the messages about KRMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	86.67%	93.33%	44.03%
Newcomers	—	13.33%	6.67%	55.97%

Nov 11

Newcomers are focusing on $KRMD's recent FDA approval for the FreedomEdge Infusion Pump, which has contributed to the stock's surge in price.
The company's third-quarter financial results have been released, showing a strong performance that may be attracting new investors.
Some users are speculating that $KRMD will continue to rise, with one user predicting a double in value with increased volume.

Generated by AI

News

KORU Medical Systems Selloff Offers An Opportunity

1mo agoSeeking Alpha

KORU Medical Systems Down On Guidance, But This Offers An Opportunity (NASDAQ:KRMD)

1mo agoSeeking Alpha

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

Company achieves 18% revenue growth and raises gross margin guidance despite international headwinds and FESGO withdrawal.

1mo agoYahoo Finance UK

Also Discussed

Investors talking about KRMD also mention

#	Name	Attention
1	Ovid Therapeutics Inc.OVID	0%0
2	TOMI Environmental Solutions, Inc.TOMZ	0%0
3	Paysign Inc.PAYS	0%new
4	Immunovant Inc.IMVT	0%0
5	ASRT - Assertio Holdings, Inc.	——
6	Eton Pharmaceuticals, Inc.ETON	0%0
7	Aprea Therapeutics, Inc.APRE	0%0
8	TCDA - Tricida, Inc.	——
9	Crexendo Inc.CXDO	0%new
10	LifeVantage CorporationLFVN	0%new

KORU Medical Systems Inc.

Healthcare
Medical Instruments & Supplies

KORU Medical Systems Inc. is a medical technology company that develops, manufactures, and commercializes subcutaneous infusion solutions for patients who require ongoing drug delivery. KORU Medical Systems Inc. focuses on home and specialty infusion care, with products designed to support the administration of therapies for chronic and complex conditions. Its portfolio includes the FREEDOM infusion systems, syringe drivers, subcutaneous safety needle sets, and precision flow rate tubing, which work together as integrated mechanical delivery solutions. The company serves healthcare providers, patients, and pharmaceutical partners in the United States and international markets, with applications across home care, emergency care, hospital settings, nursing homes, and other medical facilities. KORU Medical Systems Inc. plays a specialized role in the medical devices market by helping make subcutaneous infusion therapies more practical, patient-centric, and widely usable across different care environments.

Website

Location

100 Corporate Drive

Mahwah, NJ, 07430

United States

Social

What share of all stock conversation is about KRMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% 0

Mar 12

KORU Medical Systems reported strong Q4 and full-year 2024 financial results, with net revenues reaching $8.8M (23% YoY growth) and $33.6M (18% YoY growth), respectively.
The company achieved a gross margin of 62.9% in Q4 and 63.4% for the full year, with a cash balance of $9.6M and positive cash flow of $0.8M in Q4.
For 2025, KORU Medical projects net revenues between $38.0-$39.0M (13-16% growth) and gross margins of 61-63%, with expectations to be operational cash flow positive for the full year.

Generated by AI

Sentiment

Of the messages about KRMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% new	95.65% -2.94
Bearish	—	0%	0% -100	4.35% +2.94

Nov 11

KRMD has potential for a significant price increase, possibly reaching $7.00, driven by growing volume and FDA clearance.
The stock's recent run-up and consolidation suggest a strong chart, with the potential for further gains.
KRMD's FDA approval for the FreedomEdge infusion pump is a major catalyst, with the stock already surging in response, and potentially leading to a quadrupling in value.

Generated by AI

Topics

Of the messages about KRMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	—	36.07%
Announcements	—	—	—	21.31%
Analysts	—	—	—	4.92%
Controversies	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	37.7%

Community

Of the messages about KRMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	86.67%	93.33%	44.03%
Newcomers	—	13.33%	6.67%	55.97%

Nov 11

Newcomers are focusing on $KRMD's recent FDA approval for the FreedomEdge Infusion Pump, which has contributed to the stock's surge in price.
The company's third-quarter financial results have been released, showing a strong performance that may be attracting new investors.
Some users are speculating that $KRMD will continue to rise, with one user predicting a double in value with increased volume.

Generated by AI

KORU Medical Systems

Social

Mar 12

Nov 11

Nov 11

KORU Medical Systems Selloff Offers An Opportunity

KORU Medical Systems Down On Guidance, But This Offers An Opportunity (NASDAQ:KRMD)

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary

Earnings call transcript: KORU Medical beats Q2 2026 estimates, shares fall

KORU Medical Systems earnings beat by $0.04, revenue topped estimates

Also Discussed

KORU Medical Systems Inc.

Company Information

Location

KORU Medical Systems Selloff Offers An Opportunity

KORU Medical Systems Down On Guidance, But This Offers An Opportunity (NASDAQ:KRMD)

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary

Earnings call transcript: KORU Medical beats Q2 2026 estimates, shares fall

KORU Medical Systems earnings beat by $0.04, revenue topped estimates

Also Discussed

Social

Mar 12

Nov 11

Nov 11